SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-21-010449
Filing Date
2021-08-12
Accepted
2021-08-12 08:53:33
Documents
5
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q verv-q2-2021.htm 10-Q 2341160
2 EX-31.1 verv-20210630ex31_1.htm EX-31 15783
3 EX-31.2 verv-20210630ex31_2.htm EX-31 15788
4 EX-32.1 verv-20210630ex32_1.htm EX-32 10615
5 EX-32.2 verv-20210630ex32_2.htm EX-32 10614
  Complete submission text file 0000950123-21-010449.txt   2394942
Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Filer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40489 | Film No.: 211165632
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences